Previous 10 | Next 10 |
2023-11-13 17:33:21 ET More on Nemaura Medical Nemaura Medical says compliance regain with Nasdaq rules not expected Seeking Alpha’s Quant Rating on Nemaura Medical For further details see: Nemaura Medical reports Q2 results
Loughborough, England, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized ...
Nemaura Medical (NASDAQ: NMRD) , a medical technology company focused on developing and commercializing a daily disposable, wearable glucose sensor and supporting personalized lifestyle coaching programs, has appointed artificial intelligence (“AI”) specialist Nikolai Rozanov as s...
LOUGHBOROUGH, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc .(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive wearable diagnostic devices and supporting personalized lifesty...
2023-09-15 07:33:04 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re starting the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday! Moving stocks this morning are company updates, earnings reports...
2023-09-14 16:42:31 ET FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Nemaura Medical Provides Update on Nasdaq Compliance Status and Process.” Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”...
2023-09-14 13:17:59 ET More on Nemaura Medical Seeking Alpha’s Quant Rating on Nemaura Medical Historical earnings data for Nemaura Medical Financial information for Nemaura Medical For further details see: Nemaura Medical says compliance regain wi...
Nemaura (NASDAQ: NMRD) , a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today provided an update regarding the status of its compliance with continued listed standards and ant...
LOUGHBOROUGH, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc .(Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive wearable diagnostic devices and supporting personalized lifesty...
2023-09-13 16:43:26 ET FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health &am...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the 2024 Healthcare IT Virtual Conference. The conference will take pla...
Loughborough, UK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs, is providing a crucial update regarding recent decisions that will imp...
Loughborough, UK, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura Medical” or the “Company”), developer of a daily wear non-invasive glucose sensor, and digital healthcare programs is pleased to announce that the Nasdaq Hearings Panel gr...